Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Can The Cloud Push Microsoft Corporation Stock Past Decade-High Valuation?

By Luke Lango, InvestorPlace Senior Investment Analyst
Microsoft's growth rates continue to accelerate, fueled by its cloud business. MSFT stock is richly valued but looks good below $90.

Alnylam Pharmaceuticals (ALNY) a Buy on Healthy Quant Score

By Portfolio Grader
Currently, Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Earnings Growth Make BioMarin Pharmaceuticals (BMRN) a Sell

By Portfolio Grader
Portfolio Grader currently ranks BioMarin Pharmaceuticals (NASDAQ:BMRN) a Sell. Using Louis Navellier's investing methodology, this analytical tool researches stocks by means of fundamental and quantitative analytical tools. BMRN has maintained this ranking for 4 months.

Strong Quant Score Make Immuron Limited Sponsored ADR (IMRN) a Buy

By Portfolio Grader
The current recommendation of Buy for Immuron Limited Sponsored ADR (NULL:IMRN) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Vapid Earnings Visibility Restrict Incyte (INCY) Rating

By Portfolio Grader
Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe.

Weak Sales Growth Drop Alexion Pharmaceuticals (ALXN) to Sell

By Portfolio Grader
Alexion Pharmaceuticals Inc (NASDAQ:ALXN) is a $26.3 billion in market value component of the Biotechnology GICS industry group where The current Portfolio Grader ranking for ALXN puts it 207 among the 349 companies in this industry group, which is a below-average position. ALXN is ranked in the third quartile of the sector with a ranking of 480 among the 785 companies in the sector and number 3,109 in the 5000 company Portfolio Grader company universe.

Vertex Pharmaceuticals (VRTX) a Buy on Strong Sales Growth

By Portfolio Grader
As one of the 785 companies in the GICS Health Care sector Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a member of the 349 company Biotechnology GICS industry group within this sector. VRTX's market value is $37.9 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for VRTX puts it 81 among the 349 companies in this industry group, putting in the top quartile; in the top half of the sector with a ranking of 222 among the 785 companies in the sector, and number 1,463 in the nearly 5,000 company Portfolio Grader universe.

Adverse Earnings Growth Keep MLP & Strategic Equity Fund (MTP) a Sell

By Portfolio Grader
As one of the 785 companies in the GICS Health Care sector MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 349 company Biotechnology GICS industry group within this sector. MTP has a market value of $42.7 billion which is in the top decile in its industry group. The stock's current Portfolio Grader ranking places it 272 among the 349 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 622 among the 785 companies in the sector, and number 3,828 in the nearly 5,000 company Portfolio Grader universe.

Poor Quant Score Limit Regeneron Pharmaceuticals (REGN) Rating

By Portfolio Grader
Currently, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has a Hold using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. REGN has maintained this ranking for 5 months.

Analytics for Earnings Growth Make Shire (SHPG) a Sell

By Portfolio Grader
Currently, Shire plc (NASDAQ:SHPG) has a Sell using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months.

Etsy Inc (ETSY) Investors Profit from Strong Q3 2017 Results

By Karl Utermohlen, InvestorPlace Writer
Wall Street was expecting good things from Etsy's (ETSY) third-quarter results as shares rose over 3%, and sure enough, the company delivered.

Cellect Biotechnology (APOP) a Buy on High-Level Quant Score

By Portfolio Grader
Cellect Biotechnology Ltd (NULL:APOP) is ranked as a Buy using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Las Vegas Sands’ (LVS) Strong Earnings Visibility Keep it a Buy

By Portfolio Grader
Currently, Las Vegas Sands Corp (NYSE:LVS) has a Buy using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking LVS has had from Portfolio Grader for the last month.

Weight Watchers International, Inc. (WTW) Stock Soars on Earnings Beat

By Karl Utermohlen, InvestorPlace Writer
Weight Watchers International (WTW) posted its latest quarterly results Monday, boosting shares more than 10% after hours on earnings beat.

Earnings Growth Analytics Drive Sony (SNE) to Strong Buy

By Portfolio Grader
The current recommendation of Strong Buy for Sony Corp (NYSE:SNE) has been derived by using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. SNE has been upgraded from a Buy to a Strong Buy in the last week.

Improving Analytics Upgrade of Honda (HMC) to Hold

By Portfolio Grader
Honda Motor Co Ltd (NYSE:HMC) is a constituent of the 11 company Automobiles GICS industry group, which is a segment of the 569 company GICS Consumer Discretionary sector. The market value of HMC is $59.2 billion which places it in the upper half of its industry group. HMC is currently ranked number 7 among the 11 companies in this industry group by Portfolio Grader; in the top half of the sector with a ranking of 268 among the 569 companies in the sector, and number 2,611 in the nearly 5,000 company Portfolio Grader universe.

Tripadvisor Inc (TRIP) Revenue Falls on Disappointing Third Quarter

By Karl Utermohlen, InvestorPlace Writer
Tripadvisor (TRIP) unveiled its latest quarterly results after hours Monday, failing to meet analysts' expectations on the revenue front.

Crummy Quant Score Downgrade General Motors (GM) to Sell

By Portfolio Grader
The current recommendation of Sell for General Motors Co (NYSE:GM) is the result of using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. GM has been downgraded from a Hold to a Sell in the last week.

Earnings Visibility Hurt Colgate Palmolive Company (CL) Rating

By Portfolio Grader
Colgate Palmolive Company (NYSE:CL) is a constituent of the 14 company Household Products GICS industry group, which is a segment of the 174 company GICS Consumer Staples sector. CL's market value is $61.6 billion which falls in the top 25% of its industry group. CL is currently ranked by Portfolio Grader at number 7 among the 14 companies in this industry group; in the third quartile of the sector with a ranking of 91 among the 174 companies in the sector, and number 2,489 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles